EBITDA

Westlake seizes a German PVC plant from insolvency, a bold move that expands its global footprint and leverages unique logistical advantages on the North Sea.

When disaster strikes, 40% of small firms never reopen. A deep dive into business interruption insurance reveals what's covered, what's not, and why.

RBC's mid-year outlook reveals a resilient bull market powered by stellar earnings, but warns of historical volatility as yields and election risks loom.

The vacation rental boom largely left travel advisors behind. A new platform, Signature Stay Collection, offers a fix with curated homes and real commissions.

As autonomous AI agents begin to dominate internet traffic, a new cybersecurity battleground is emerging. We explore the shift to agent trust management.

A silent productivity drain is costing businesses dearly. Over half the workforce aged 40-60 is managing elder care, and the financial and career toll is immense.

Fulton Bank's latest CSR report details hundreds of millions in community investment. Is this just philanthropy, or a calculated strategy for lasting resilience?

Chicago's Automate 2026 isn't just a tech show. It's a critical look at how AI and robotics are solving today's business crises and shaping future profits.

A seasoned investment team leaves the world of institutional giants to bring their emerging market strategy to the public through two new actively managed ETFs.

In a year with the fewest home sales since 2007, one Nevada real estate team didn't just survive; it dominated. Here's how they did it.

Lexeo Therapeutics finalizes a pivotal trial for its Friedreich ataxia gene therapy, leveraging a novel trial design and accelerated FDA pathway.

Beyond a steady distribution, Chartwell's latest update signals a bold repositioning strategy. What does it mean for investors and the market?

Gilat's acquisition of a key Comtech division isn't just a purchase; it's a strategic power play to build a $700M defense tech giant for a new era.

After its transformative Plains NGL acquisition, Keyera unveils an aggressive growth plan targeting 16% CAGR, promising a new era of shareholder value.

ING elevates its HR chief to the management board, a strategic bet that human capital, not just financial capital, will define the future of banking.

Stunning new US/EU data for BTK inhibitor orelabrutinib signals a major push into Western markets, challenging established blood cancer therapies.

A legacy steel tube maker is betting its future on geothermal energy, driven by AI's insatiable power needs. Is this the most critical pivot in the energy transition?

Chaka Khan's partnership with HarbourView isn't just a deal; it's a look into the future of music, where finance and artistry create a new kind of legacy.

Mantle's new AI-native prediction market, InsightX, isn't just about forecasts. It's an 'InfoFi' play where capital never sleeps, a key growth signal.

Jurupa Community Services District's national recognition isn't just an award; it's a strategic model for how investing in people drives superior service.